aetna medicare solution

WOW! Great news: Formulary enhancements for 2023

Starting in 2023, many of the top medications taken by Aetna Medicare members will be on a lower drug tier, Tiers 1 and 2. In fact, nearly 300 drugs are moving to a lower drug tier.


This includes drugs for asthma, depression, anxiety, and more. And many drugs for high blood pressure and high cholesterol are already on Tiers 1 and 2.

What’s the big deal?

These formulary updates may help members save on prescription costs.

For example, some of the Tier 3 drugs moving to Tier 2 include:

  • b) ESCITALOPRAM OXALATE (depression, anxiety)
  • c) CELECOXIB (pain relief, inflammation)
  • d) BUPROPION HYDROCHLORIDE ER (XL) (depression, smoking cessation)

Other fun facts

  • a) We’ve down-tiered nearly 300 drugs across each of our formularies: B2:         294; B4/B4+: 279; B5: 278 
  • b) Improved the volume of Tier 1 and 2 drugs on our MAPD formularies by           45% (compared with 2022) 
  • c) Nearly 8 in 10 members will continue to have access to $0/$0 Tier 1 and         2 copay structure 
  • d) Added ~10 new drugs to MAPD formularies including popular drugs such      as:
    •      i) Eligard (prostate cancer)
    •      ii) Gemtesa (overactive bladder)
    •      iii) Lantus (diabetes)*
    •      iiiv) Toujeo (diabetes)*
    •      v) Truxima (biosimilar, rheumatoid arthritis)

 *Drug already on B5+ in 2022


We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact or 1-800-MEDICARE to get information on all of your options.

我们无法提供您所在地区全部的计划,我们提供的内容仅限于我们在您所在的地区能提供的保险方案。 如需了解所有计划选择,请浏览Medicare.Gov或致电1-800-Medicare